Harnessing dendritic cells in cancer

Gao, 2003, Gamma delta T cells provide an early source of interferon gamma in tumor immunity, J Exp Med, 198, 433, 10.1084/jem.20030584 Borg, 2004, Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects, J Clin Invest, 114, 379, 10.1172/JCI21102 Smyth, 2001, A fresh look at tumor immunosurveillance and immunotherapy, Nat Immunol, 2, 293, 10.1038/86297 Hildner, 2008, Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity, Science, 322, 1097, 10.1126/science.1164206 Crowe, 2002, A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas, J Exp Med, 196, 119, 10.1084/jem.20020092 Shankaran, 2001, IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, 410, 1107, 10.1038/35074122 Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588 Shortman, 2002, Mouse and human dendritic cell subtypes, Nat Rev Immunol, 2, 151, 10.1038/nri746 Chaput, 2008, The Janus face of dendritic cells in cancer, Oncogene, 27, 5920, 10.1038/onc.2008.270 Zou, 2005, Immunosuppressive networks in the tumour environment and their therapeutic relevance, Nat Rev Cancer, 5, 263, 10.1038/nrc1586 Picaud, 2002, Enhanced tumor development in mice lacking a functional type I interferon receptor, J Interferon Cytokine Res, 22, 457, 10.1089/10799900252952244 Hartmann, 2003, Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer, Cancer Res, 63, 6478 Cao, 2009, Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction, J Exp Med, 206, 1603, 10.1084/jem.20090547 Cao, 2006, Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production, J Exp Med, 203, 1399, 10.1084/jem.20052454 Cho, 2008, SAGE library screening reveals ILT7 as a specific plasmacytoid dendritic cell marker that regulates type I IFN production, Int Immunol, 20, 155, 10.1093/intimm/dxm127 Novitskiy, 2008, Adenosine receptors in regulation of dendritic cell differentiation and function, Blood, 112, 1822, 10.1182/blood-2008-02-136325 Pardoll, 2004, Cancer immunotherapy: breaking the barriers to harvest the crop, Nat Med, 10, 887, 10.1038/nm0904-887 Kortylewski, 2005, Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity, Nat Med, 11, 1314, 10.1038/nm1325 Cheng, 2003, A critical role for Stat3 signaling in immune tolerance, Immunity, 19, 425, 10.1016/S1074-7613(03)00232-2 Ahmadi, 2008, Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo, Cancer Res, 68, 7520, 10.1158/0008-5472.CAN-08-1060 Yang, 2003, Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor, J Clin Invest, 111, 727, 10.1172/JCI16492 von Bergwelt-Baildon, 2006, CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition, Blood, 108, 228, 10.1182/blood-2005-08-3507 Cheng, 2008, Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein, J Exp Med, 205, 2235, 10.1084/jem.20080132 Chalmin, 2010, Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells, J Clin Invest, 120, 457 Villablanca, 2010, Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses, Nat Med, 16, 98, 10.1038/nm.2074 Herber, 2010, Lipid accumulation and dendritic cell dysfunction in cancer, Nat Med, 16, 880, 10.1038/nm.2172 GeurtsvanKessel, 2009, Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice, J Exp Med, 206, 2339, 10.1084/jem.20090410 Dieu-Nosjean, 2008, Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures, J Clin Oncol, 26, 4410, 10.1200/JCO.2007.15.0284 Lee, 2006, Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure, Immunity, 25, 499, 10.1016/j.immuni.2006.06.016 Thompson, 2010, Tumor masses support naive T cell infiltration, activation, and differentiation into effectors, J Exp Med, 207, 1791, 10.1084/jem.20092454 Shields, 2010, Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21, Science, 328, 749, 10.1126/science.1185837 Janssen, 2006, Efficient T cell activation via a toll-interleukin 1 receptor-independent pathway, Immunity, 24, 787, 10.1016/j.immuni.2006.03.024 Krebs, 2009, NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses, Blood, 113, 6593, 10.1182/blood-2009-01-201467 Levitsky, 1994, In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression, J Exp Med, 179, 1215, 10.1084/jem.179.4.1215 Mocikat, 2003, Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses, Immunity, 19, 561, 10.1016/S1074-7613(03)00264-4 Diefenbach, 2001, Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity, Nature, 413, 165, 10.1038/35093109 Kelly, 2002, Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection, Nat Immunol, 3, 83, 10.1038/ni746 Brandt, 2009, The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans, J Exp Med, 206, 1495, 10.1084/jem.20090681 Messi, 2003, Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes, Nat Immunol, 4, 78, 10.1038/ni872 Vitale, 2005, NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor, Blood, 106, 566, 10.1182/blood-2004-10-4035 Morandi, 2006, NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion, Eur J Immunol, 36, 2394, 10.1002/eji.200636290 Kalinski, 2005, Helper role of NK cells during the induction of anticancer responses by dendritic cells, Mol Immunol, 42, 535, 10.1016/j.molimm.2004.07.038 Adam, 2005, DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction, Blood, 106, 338, 10.1182/blood-2004-09-3775 Andrews, 2010, Innate immunity defines the capacity of antiviral T cells to limit persistent infection, J Exp Med, 207, 1333, 10.1084/jem.20091193 Fujii, 2004, The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation, J Exp Med, 199, 1607, 10.1084/jem.20040317 Semmling, 2010, Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs, Nat Immunol, 11, 313, 10.1038/ni.1848 Taieb, 2006, A novel dendritic cell subset involved in tumor immunosurveillance, Nat Med, 12, 214, 10.1038/nm1356 Ullrich, 2008, Trans-presentation of IL-15 dictates IFN-producing killer dendritic cells effector functions, J Immunol, 180, 7887, 10.4049/jimmunol.180.12.7887 Terme, 2009, The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells, Cancer Res, 69, 6590, 10.1158/0008-5472.CAN-08-4473 Koebel, 2007, Adaptive immunity maintains occult cancer in an equilibrium state, Nature, 450, 903, 10.1038/nature06309 Dunn, 2005, A critical function for type I interferons in cancer immunoediting, Nat Immunol, 6, 722, 10.1038/ni1213 Sancho, 2009, Identification of a dendritic cell receptor that couples sensing of necrosis to immunity, Nature, 458, 899, 10.1038/nature07750 Poulin, 2010, Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells, J Exp Med, 207, 1261, 10.1084/jem.20092618 Crozat, 2010, The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells, J Exp Med, 207, 1283, 10.1084/jem.20100223 Jongbloed, 2010, Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens, J Exp Med, 207, 1247, 10.1084/jem.20092140 Contreras, 2010, Existence of CD8{alpha}-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species, J Immunol, 185, 3313, 10.4049/jimmunol.1000824 Lin, 2008, The cell biology of cross-presentation and the role of dendritic cell subsets, Immunol Cell Biol, 86, 353, 10.1038/icb.2008.3 Pages, 2005, Effector memory T cells, early metastasis, and survival in colorectal cancer, N Engl J Med, 353, 2654, 10.1056/NEJMoa051424 Zammit, 2005, Dendritic cells maximize the memory CD8 T cell response to infection, Immunity, 22, 561, 10.1016/j.immuni.2005.03.005 Belz, 2006, Bone marrow-derived cells expand memory CD8+ T cells in response to viral infections of the lung and skin, Eur J Immunol, 36, 327, 10.1002/eji.200535432 McDonnell, 2010, CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor, Eur J Immunol, 40, 1617, 10.1002/eji.200940153 Belz, 2007, Minimal activation of memory CD8+ T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+ T cells, Nat Immunol, 8, 1060, 10.1038/ni1505 Mayordomo, 1995, Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity, Nat Med, 1, 1297, 10.1038/nm1295-1297 Zitvogel, 1996, Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells B7 costimulation, and T helper cell 1-associated cytokines, J Exp Med, 183, 87, 10.1084/jem.183.1.87 Fernandez, 1999, Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo, Nat Med, 5, 405, 10.1038/7403 Zitvogel, 1998, Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes, Nat Med, 4, 594, 10.1038/nm0598-594 Shimizu, 2007, Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells, J Exp Med, 204, 2641, 10.1084/jem.20070458 Ali, 2009, In situ regulation of DC subsets and T cells mediates tumor regression in mice, Sci Transl Med, 1, ra19, 10.1126/scitranslmed.3000359 Trinite, 2000, A subset of cytolytic dendritic cells in rat, J Immunol, 165, 4202, 10.4049/jimmunol.165.8.4202 Trinite, 2005, Immature CD4− CD103+ rat dendritic cells induce rapid caspase-independent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims, J Immunol, 175, 2408, 10.4049/jimmunol.175.4.2408 Alli, 2004, Involvement of NKR-P2/NKG2D in DC-mediated killing of tumor targets: indicative of a common, innate, target-recognition paradigm?, Eur J Immunol, 34, 1119, 10.1002/eji.200324793 Chan, 2006, Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity, Nat Med, 12, 207, 10.1038/nm1352 Roux, 2008, CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer, J Clin Invest, 118, 3751, 10.1172/JCI35890 Tsuji, 2000, Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors, Infect Immun, 68, 6883, 10.1128/IAI.68.12.6883-6890.2000 Lee, 2004, Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients, J Immunol, 172, 7335, 10.4049/jimmunol.172.12.7335 Ghiringhelli, 2005, Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation, J Exp Med, 202, 919, 10.1084/jem.20050463 Jung, 2002, In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens, Immunity, 17, 211, 10.1016/S1074-7613(02)00365-5 Apetoh, 2007, Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Nat Med, 13, 1050, 10.1038/nm1622 Obeid, 2007, Calreticulin exposure dictates the immunogenicity of cancer cell death, Nat Med, 13, 54, 10.1038/nm1523 Apetoh, 2007, The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy, Immunol Rev, 220, 47, 10.1111/j.1600-065X.2007.00573.x Apetoh, 2008, Immunogenicity of anthracyclines: moving towards more personalized medicine, Trends Mol Med, 14, 141, 10.1016/j.molmed.2008.02.002 Ghiringhelli, 2009, Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors, Nat Med, 15, 1170, 10.1038/nm.2028 Sluyter, 2004, Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes, J Immunol, 172, 3399, 10.4049/jimmunol.172.6.3399 Ramakrishnan, 2009, Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice, J Clin Invest, 120, 1111, 10.1172/JCI40269 Taieb, 2006, Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines, J Immunol, 176, 2722, 10.4049/jimmunol.176.5.2722 Nowak, 2003, Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells, J Immunol, 170, 4905, 10.4049/jimmunol.170.10.4905 Vincent, 2010, 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity, Cancer Res, 70, 3052, 10.1158/0008-5472.CAN-09-3690 Hsu, 1996, Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells, Nat Med, 2, 52, 10.1038/nm0196-52 Timmerman, 2002, Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients, Blood, 99, 1517, 10.1182/blood.V99.5.1517 Nestle, 1998, Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells, Nat Med, 4, 328, 10.1038/nm0398-328 Thurner, 1999, Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma, J Exp Med, 190, 1669, 10.1084/jem.190.11.1669 Fong, 2001, Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy, Proc Natl Acad Sci USA, 98, 8809, 10.1073/pnas.141226398 Morse, 1999, Migration of human dendritic cells after injection in patients with metastatic malignancies, Cancer Res, 59, 56 de Vries, 2005, Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy, Nat Biotechnol, 23, 1407, 10.1038/nbt1154 Kantoff, 2010, Sipuleucel-T immunotherapy for castration-resistant prostate cancer, N Engl J Med, 363, 411, 10.1056/NEJMoa1001294 Bonifaz, 2002, Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance, J Exp Med, 196, 1627, 10.1084/jem.20021598 Bonifaz, 2004, In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination, J Exp Med, 199, 815, 10.1084/jem.20032220 Birkholz, 2010, Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation, Blood, 116, 2277, 10.1182/blood-2010-02-268425 Klechevsky, 2010, Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR, Blood, 116, 1685, 10.1182/blood-2010-01-264960 Klechevsky, 2008, Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells, Immunity, 29, 497, 10.1016/j.immuni.2008.07.013 Idoyaga, 2008, Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo, J Immunol, 180, 3647, 10.4049/jimmunol.180.6.3647 Manicassamy, 2009, Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity, Nat Med, 15, 401, 10.1038/nm.1925